Free Trial

Natera (NTRA) News Today

$111.19
+1.97 (+1.80%)
(As of 06/7/2024 ET)
RTW Investments LP Trims Holdings in Natera, Inc. (NASDAQ:NTRA)
RTW Investments LP decreased its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 2.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,593,323 shares of the medical research company's stock after selling 58,460 shares du
Natera (NASDAQ:NTRA) Reaches New 12-Month High at $110.92
Natera (NASDAQ:NTRA) Reaches New 1-Year High at $110.92
Rafferty Asset Management LLC Lowers Position in Natera, Inc. (NASDAQ:NTRA)
Rafferty Asset Management LLC trimmed its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 6.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 154,404 shares of the medical research company's stock after se
Rhenman & Partners Asset Management AB Sells 21,769 Shares of Natera, Inc. (NASDAQ:NTRA)
Rhenman & Partners Asset Management AB lowered its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 8.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 245,000 shares of the medical resea
Campbell & CO Investment Adviser LLC Raises Stock Holdings in Natera, Inc. (NASDAQ:NTRA)
Campbell & CO Investment Adviser LLC raised its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 1,094.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,874 shares of the medical research comp
Natera: Overdue For A Breather
Crestline Management LP Grows Holdings in Natera, Inc. (NASDAQ:NTRA)
Crestline Management LP lifted its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 16.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,070 shares of the medical research company's stock after buying an
Natera, Inc. (NASDAQ:NTRA) Director Gail Boxer Marcus Sells 2,000 Shares
Natera, Inc. (NASDAQ:NTRA - Get Free Report) Director Gail Boxer Marcus sold 2,000 shares of the firm's stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $110.17, for a total transaction of $220,340.00. Following the completion of the sale, the director now owns 18,634 shares of the company's stock, valued at $2,052,907.78. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Natera, Inc. (NASDAQ:NTRA) Insider Solomon Moshkevich Sells 1,647 Shares
Natera, Inc. (NASDAQ:NTRA - Get Free Report) insider Solomon Moshkevich sold 1,647 shares of the business's stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $109.96, for a total transaction of $181,104.12. Following the transaction, the insider now directly owns 114,186 shares in the company, valued at $12,555,892.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Weiss Asset Management LP Acquires Shares of 7,240 Natera, Inc. (NASDAQ:NTRA)
Weiss Asset Management LP acquired a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 7,240 shares of the medical research company's stock, valued at approximately $454,000. Several other i
Natera (NASDAQ:NTRA) Reaches New 1-Year High at $110.66
Natera (NASDAQ:NTRA) Sets New 1-Year High at $110.66
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Nomura Asset Management Co. Ltd.
Nomura Asset Management Co. Ltd. lessened its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 3.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 202,632 shares of the medical research company's stock after selling 8,332
20,905 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by Millrace Asset Group Inc.
Millrace Asset Group Inc. bought a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 20,905 shares of the medical research company's stock, valued at approximately $1,30
Norges Bank Purchases New Shares in Natera, Inc. (NASDAQ:NTRA)
Norges Bank acquired a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,340,514 shares of the medical research company's stock, valued at approximately $8
TCW Group Inc. Increases Stock Holdings in Natera, Inc. (NASDAQ:NTRA)
TCW Group Inc. boosted its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 16.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 67,237 shares of the medical research company's stock after buying an additional 9,724 shares during the perio
Natera (NASDAQ:NTRA) Hits New 1-Year High at $109.67
Natera (NASDAQ:NTRA) Hits New 52-Week High at $109.67
Trexquant Investment LP Has $7.44 Million Position in Natera, Inc. (NASDAQ:NTRA)
Trexquant Investment LP grew its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 574.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 118,758 shares of the medical research company's stock after purchasing an additional 101,1
Massachusetts Financial Services Co. MA Invests $27.63 Million in Natera, Inc. (NASDAQ:NTRA)
Massachusetts Financial Services Co. MA bought a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 441,024 shares of the medical research company's stock, valued at approximately $27,626,000. Massac
Natera, Inc. (NASDAQ:NTRA) CEO Sells $725,895.32 in Stock
Natera, Inc. (NASDAQ:NTRA - Get Free Report) CEO Steven Leonard Chapman sold 6,779 shares of the stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $107.08, for a total transaction of $725,895.32. Following the completion of the transaction, the chief executive officer now directly owns 219,456 shares in the company, valued at $23,499,348.48. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Natera, Inc. (NASDAQ:NTRA) Shares Bought by BNP Paribas Financial Markets
BNP Paribas Financial Markets increased its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 375.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 183,375 shares of the medical research company's stock after purchasing a
Natera (NASDAQ:NTRA) Sets New 12-Month High at $108.51
Natera (NASDAQ:NTRA) Sets New 12-Month High at $108.51
Natera, Inc. (NASDAQ:NTRA) Shares Acquired by Jump Financial LLC
Jump Financial LLC lifted its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 128.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,221 shares of the medical research company's stock after acqui
Natera (NASDAQ:NTRA) Price Target Raised to $120.00
Piper Sandler raised their price target on shares of Natera from $110.00 to $120.00 and gave the stock an "overweight" rating in a report on Tuesday.
Key Takeaways From Natera Analyst Ratings
Natera, Inc. (NASDAQ:NTRA) Shares Bought by Principal Financial Group Inc.
Principal Financial Group Inc. raised its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 7.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,703,615 shares of the medical research company's stoc
Natera (NASDAQ:NTRA) Price Target Raised to $125.00 at BTIG Research
BTIG Research boosted their target price on Natera from $100.00 to $125.00 and gave the company a "buy" rating in a report on Monday.
Hamilton Lane Advisors LLC Buys Shares of 9,833 Natera, Inc. (NASDAQ:NTRA)
Hamilton Lane Advisors LLC bought a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 9,833 shares of the medical research company's stock, valued at approximately $616,000. Na
Swiss National Bank Sells 16,600 Shares of Natera, Inc. (NASDAQ:NTRA)
Swiss National Bank trimmed its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 7.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 222,100 shares of the medical research company's stock after selling 16,600
Natera (NASDAQ:NTRA) Announces Earnings Results, Beats Expectations By $0.16 EPS
Natera (NASDAQ:NTRA - Get Free Report) issued its quarterly earnings results on Thursday. The medical research company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.72) by $0.16. Natera had a negative return on equity of 62.19% and a negative net margin of 40.16%. The company had revenue of $367.70 million for the quarter, compared to analyst estimates of $316.31 million. The company's revenue for the quarter was up 52.1% compared to the same quarter last year. During the same quarter last year, the company posted ($1.23) EPS.
Natera (NASDAQ:NTRA) Reaches New 1-Year High After Earnings Beat
Natera (NASDAQ:NTRA) Reaches New 12-Month High Following Strong Earnings
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Truist Financial Corp
Truist Financial Corp lowered its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 18.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,166 shares of the medical research company's stock after selling 8,644
Craig-Hallum Keeps Their Buy Rating on Natera (NTRA)

NTRA Media Mentions By Week

NTRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NTRA
News Sentiment

1.04

0.75

Average
Medical
News Sentiment

NTRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NTRA Articles
This Week

13

6

NTRA Articles
Average Week

Get Natera News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NTRA) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners